Rubicon Research IPO

Issue period

Opens On:

Closes On:

Price band

₹ 0 to 0 per equity share

Bid lot

0 shares and in multiples thereof

APPLY NOW

Don't have a Sharekhan account?
Open demat account in 15 mins*!

More about the IPO Company details How to apply IPO online How does an IPO work?

More about the IPO

Issue size	Rs. 0 Cr
Price band	Rs. 0 to 0 per equity share
Bid lot	0 shares and in multiples thereof
Issue break-up	QIB - Rs. 0.0 Cr
	HNI - Rs. 0.0 Cr
	RET - Rs. 0.0 Cr
Registrar
Listing at

Company Details

We are a pharmaceutical formulations company, driven by innovation through focused research and development, with an increasing portfolio of specialty products and drug-device combination products targeting regulated markets and in particular the United States. Based on the peer set (of six listed Indian companies assessed by F&S, and our Company), we are the only Indian pharmaceutical player with a complete focus on regulated markets. (Source: F&S Report)

According to F&S, between Fiscals 2022 and 2024, we were the fastest growing Indian pharmaceuticals formulations company with a CAGR for total revenue of 62.5% which was five times higher than the average (of 11 companies, including us) assessed by F&S. According to F&S, in Fiscal 2024, we ranked among the top 10 Indian companies in terms of total Abbreviated New Drug Application (“ANDA”) approvals. We received 14 ANDA approvals from the US FDA in Fiscal 2024, 12 ANDA approvals in Fiscal 2023 and nine ANDA approvals in Fiscal 2022.

According to F&S, in Fiscal 2024, among our 55 commercialized products (“Commercialized Products”) in the US, we held a market share of more than 25% by volume for seven products. Furthermore, according to F&S, none of our manufacturing facilities have received an “Official Action Indicated” (“OAI”) status by the US FDA since 2013.

We believe our multi-disciplinary, data-driven, and return on investment (“ROI”) centric product selection framework is geared towards identifying sustainable opportunities for new product development. We identify and pursue such opportunities in a manner that provides us a competitive advantage by leveraging our development, manufacturing, and commercialization capabilities to create and grow our share of the market.

As on March 31, 2024, we had a portfolio of 69 active1 ANDA and New Drug Application (“NDA”) products approved by the US FDA. According to F&S, our Company’s portfolio includes 55 Commercialized Products, with a US generic pharmaceutical market size of USD 2,386.6 million, of which the Company contributed USD 154.3 million in Fiscal 2024. These products are being marketed and are available for purchase by customers in the US.

Log in to the Mirae Asset Sharekhan app and tap the hamburger menu.
Under the EQUITY dropdown option, tap IPO/OFS/BOND to land on the IPO dashboard.
Click on the Current IPO tab and select the IPO of your choice.
On the IPO application form that opens, fill in details like the Demat Account Number, Category of investor, number of lots you wish to invest in, the Cut-Off Price and others.
Now enter your UPI ID (make sure this UPI ID is connected to your Mirae Asset Sharekhan-mapped bank account) on the form.
Read and accept the Terms & Conditions and click on the SUBMIT button. Recheck the details on the order confirmation screen and confirm the order.
Once the exchange receives details about your bid, you will get a notification (IPO mandate request) on your UPI app and an SMS as well.
Log in to your UPI app and go to the pending mandates section.
Verify all the details once again and authenticate your bid amount by entering your UPI PIN.
Once done, the IPO application amount will be blocked and you will receive an SMS about the blocked Bid amount.

Note: The actual amount will be debited when the shares are allotted to you.

How to apply for an IPO on the Mirae Asset Sharekhan app

How to apply for an IPO on the Mirae Asset Sharekhan website

Log in to the Mirae Asset Sharekhan website and click the IPO & OTHERS menu option you see on the top-right.
From the list of Active IPOs, select the IPO of your choice
On the IPO application form that opens, fill in details like the Demat Account Number, Category of investor, number of lots you wish to invest in, the Cut-Off Price and others.
Now enter your UPI ID (make sure this UPI ID is connected to your Mirae Asset Sharekhan-mapped bank account) on the form. Read and accept the Terms & Conditions and click on the SUBMIT button.
Recheck the details on the order confirmation screen and confirm the order.
Once the exchange receives details about your bid, you will get a notification (IPO mandate request) on your UPI app and an SMS as well. Log in to your UPI app and go to the pending mandates section.
Verify all the details once again and authenticate your bid amount by entering your UPI PIN.
Once done, the IPO application amount will be blocked and you will receive an SMS about the blocked Bid amount.
Your IPO order will now appear on your Mirae Asset Sharekhan Order Book, from where you can modify or cancel your IPO bid if you so wish.

Note: The actual amount will be debited when the shares are allotted to you.

How does an IPO work?

An IPO offers share market participants like you and me an opportunity to be a shareholder in an erstwhile privately held company that is now going public and being listed on the market. Historically speaking, investors who choose the right IPOs make significant returns on their investments, which increases the attraction of IPOs.

Once you are a shareholder, you are eligible to receive dividends from the company proportional to the shares you own. You can also sell your stocks for profit on the stock exchange.

In exchange for its shares, the company has an opportunity to raise huge capital to be used to further enhance its business and scale up its operations. The company also has other benefits, such as credibility; visibility; better leverage to effect mergers, acquisitions and even to procure loans at lower rates of interest.

In India, the entire IPO process is ably regulated by the Securities & Exchange Board of India (SEBI), right from the IPO filing by the company to the bidding, allotments and refunds (in case you aren't allotted shares due to oversubscription).

IPO Calendar

List of IPOs

Active Infrastructures Ltd.

Price: 178 - 181 | IPO Lot Size: 600 | IPO Issue Size: NA
Open Date: 21 Mar 2025 | Close Date: 25 Mar 2025

Rubicon Research IPO

Issue period

Price band

Bid lot

More about the IPO

Company Details

How to apply for an IPO on the Mirae Asset Sharekhan app

How to apply for an IPO on the Mirae Asset Sharekhan website

How does an IPO work?

IPO Calendar

List of IPOs

Active Infrastructures Ltd.

Rapid Fleet Management Services Ltd.

Grand Continent Hotels Ltd.

Desco Infratech Ltd.

ATC Energies System Ltd.

Shri Ahimsa Naturals Ltd.

Go Airlines (India) Ltd.

Identixweb Ltd.

Snapdeal Ltd.

National Securities Depository Ltd.

Lava International Ltd.

Navi Technologies Ltd

BMW Ventures Ltd.

VLCC Healthcare ltd

Oravel Stays Ltd.

Schloss Bangalore Ltd.

Seven Seaz Vacations Ltd.

Sunshine Pictures Ltd.

Wework India Management Pvt. Ltd.

Indogulf Cropsciences Ltd.

Innovision Ltd.

Viney Corporation Ltd.

Survival Technologies Ltd.

Onest Ltd.

Park Smart Solutions Ltd.

Netanalytiks Technologies Ltd.

Skill Tree Consulting Ltd.

Icon Facilitators Ltd.

Durgadevi Raiment Ltd.

Ultra Rich Weddings Ltd.

Repono Ltd.

Inductus Ltd.

Sugs Lloyd Ltd.

Spinaroo Commercial Ltd.

Valencia India Ltd.

Safecure Services Ltd.

Earthood Services Ltd.

Shanti Gold International Ltd.

Euro Pratik Sales Ltd.

Innovatiview India Ltd.

Speciality Molecules Ltd.

Star Agriwarehousing & Collateral Managment Ltd.

Deltatech Gaming Ltd.

Bluestone Jewellery And Lifestyle Pvt. Ltd.

Adcounty Media India Ltd.

Rachit Prints Ltd.

Corrtech International Pvt.Ltd.

Kalpataru Ltd.

Seedworks International Pvt.Ltd.

Balaji Solutions Pvt. Ltd.

VMS TMT Ltd.

B R Goyal Infrastructure Ltd (Old)

Ciel Hr Services Pvt Ltd

Course5 Intelligence Ltd

Euro Pratik Ispat (India) Private Ltd

Fujiyama Power Systems Pvt Ltd

Lcc Projects Pvt Ltd

Ganesh Consumer Products Ltd.

Shiva Pharmachem Ltd.

Wellness Forever Medicare Ltd.

Richesm Healthcare Ltd.

Anlon Healthcare Ltd.

Speciality Medicines Ltd.

Asston Pharmaceuticals Ltd.

Kent R O Systems Ltd.

Riddhi Display Equipments Ltd.

Hexaware Technologies Ltd.(Old)

LG Electronics India Ltd.

Imagine Marketing Ltd.